The translational implications of the interdependence between estrogenic and hypoxic signaling mediated by ER and/or GPER together with HIF-1α could deeply impact the development of novel combination strategies aimed at inhibiting breast cancer progression and overcoming anti-cancer drug resistance. Here, HIF1A is linked to breast carcinoma.